Recently, LOTTE BIOLOGICS had the privilege of participating in the influential "Invest Fair" of BIO KOREA 2023, held at COEX Exhibition Hall from May 10-12. The Investor Fair is an esteemed platform for groundbreaking biotech firms, providing the opportunity to highlight their innovative technologies, attract meaningful investment, and extend their influence within the domestic and global markets of the bio health industry.
 

Among the engaging activities at the conference, LOTTE BIOLOGICS contributed to the insightful dialogue during the Vaccine section, one of the six sessions organized on the event's third day. Our very own Michael Hausladen, the General Manager of LOTTE BIOLOGICS USA, delivered a comprehensive presentation.
 

Hausladen showcased the advanced production capabilities of our Syracuse plant in the U.S. and shared our thoughtful medium-to-long-term business strategy, offering attendees a glimpse into our future plans.